(Q34348296)

1 August 2017

1 reference

title

Complementary and alternative therapies for advanced prostate cancer (English)

1 reference

1 August 2017

1 reference

M R Smith

1

1 reference

1 August 2017

publication date

1 June 2001

1 reference

Hematology / Oncology Clinics of North America

1 August 2017

published in

1 reference

1 August 2017

volume

15

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

559-571

1 reference

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Anemia associated with advanced prostatic adenocarcinoma: effects of recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Current use of bisphosphonates in oncology. International Bone and Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Treatment of painful prostatic bone metastases with oral etidronate disodium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Binding of permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Osteoclast inhibition by pamidronate in metastatic prostate cancer: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Disodium pamidronate identifies differential osteoclastic bone resorption in metastatic prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Progressive osteoporosis during androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: a preliminary investigation on human cell lines and patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Inhibition of the activity of 'basic' 5 alpha-reductase (type 1) detected in DU 145 cells and expressed in insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Reduction in new metastases in breast cancer with adjuvant clodronate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Effect of oral clodronate on bone pain. A controlled study in patients with metastic prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Saw palmetto for the treatment of men with lower urinary tract symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Transdermal estrogen in the treatment of hot flushes in men with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Human prostatic steroid 5α-reductase isoforms—A comparative study of selective inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

A phase 1-2 trial of diethylstilbestrol plus low dose warfarin in advanced prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

PC-SPES: a unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo .

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the finnish prostate cancer group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

A review of the effectiveness of Cimicifuga racemosa (black cohosh) for the symptoms of menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Megestrol Acetate for the Prevention of Hot Flashes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Treatment of castration-induced menopausal symptoms with low dose diethylstilbestrol in men with advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Bisphosphonates as anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Low-dose continuous oral fosfestrol is highly active in 'hormone-refractory' prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Effects of the bisphosphonate olpadronate in patients with carcinoma of the prostate metastatic to the skeleton

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

PC-SPES, a dietary supplement for the treatment of hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Effects of dichloromethylene diphosphonate on the osteolytic and osteoplastic effects of rat prostate adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Multicenter, randomized, double-blind, placebo controlled study to investigate the effect of finasteride (MK-906) on stage D prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Androgens, brain, and behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Testosterone and depression in aging men

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Palliation of painful bone metastases from prostate cancer using sodium etidronate: results of a randomized, prospective, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Progression delay of prostate tumor skeletal metastasis effects by bisphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

A systematic review of newer pharmacotherapies for depression in adults: evidence report summary

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970232-X

7 January 2021

10.1016/S0889-8588(05)70232-X

Identifiers

DOI

1 reference

1 August 2017

1 reference